search
Back to results

Effects of RAS on Gait in PD Patients With DBS

Primary Purpose

Parkinson Disease

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Rhythmic Auditory Stimulation (RAS)
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Parkinson Disease focused on measuring Parkinson disease, Deep brain stimulation, Rhythmic auditory stimulation

Eligibility Criteria

18 Years - 89 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients diagnosed with Parkinson disease (PD) (and) PD patients who implanted Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) with PerceptTM PC Exclusion Criteria: Inability or unwillingness to follow directions for study procedures

Sites / Locations

  • Johns Hopkins School of MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

No Intervention

Arm Label

Pre RAS

During RAS

Post RAS

Arm Description

After a 10-minute washout period, participants will receive the participants' optimized stimulation. The participants will undergo assessments to measure gait parameters and patterns during stimulation ON and OFF (Pre-RAS) using the 10-meter walk (during a 2-minute walk) and MDS-UPDRS-III rating scale. Electrophysiological activity (e.g., local field potentials, LFPs) will be collected before assessments.

The participants will walk to the metronome beats for four minutes (2 minutes for the same beats as baseline cadence and 2 minutes for 10% faster than baseline cadence) (RAS), and the participants' gait parameters will be recorded. Electrophysiological activity (e.g., local field potentials, LFPs) will be collected.

The same assessment as the Pre-RAS will be conducted (Post-RAS).

Outcomes

Primary Outcome Measures

Change in gait cadence (steps/minute)
Gait cadence will be calculated with a 10-meter walk. Cadence (steps/min) = 60 / time (seconds) x # of steps
Change in gait velocity (meter/minute)
Gait velocity will be calculated with a 10-meter walk. Velocity(meter/min) = 60 / time (seconds) x 10 meter
Change in gait stride length (meter)
Gait stride length will be calculated with a 10-meter walk. Stride length (meter) = Velocity / Cadence x 2
Changes in MDS-UPDRS-III (section 3.9. Arising From Chair ) score
0: Normal: No problems. Able to arise quickly without hesitation. Slight: Arising is slower than normal; or may need more than one attempt; or may need to move forward in the chair to arise. No need to use the arms of the chair. Mild: Pushes self up from the arms of the chair without difficulty. Moderate: Needs to push off, but tends to fall back; or may have to try more than one time using the arms of the chair, but can get up without help. Severe: Unable to arise without help.
Change in MDS-UPDRS-III (section 3.10. Gait) score
0: Normal: No problems. Slight: Independent walking with minor gait impairment. Mild: Independent walking but with substantial gait impairment. Moderate: Requires an assistance device for safe walking (walking stick, walker) but not a person. Severe: Cannot walk at all or only with another person's assistance.
Change in MDS-UPDRS-III (section 3.11. Freezing of gait) score
0: Normal: No freezing. Slight: Freezes on starting, turning, or walking through doorway with a single halt during any of these events, but then continues smoothly without freezing during straight walking. Mild: Freezes on starting, turning, or walking through doorway with more than one halt during any of these activities, but continues smoothly without freezing during straight walking. Moderate: Freezes once during straight walking. Severe: Freezes multiple times during straight walking.
Change in MDS-UPDRS-III (section 3.12. Postural stability) score
0: Normal: No problems. Recovers with one or two steps. Slight: 3-5 steps, but subject recovers unaided. Mild: More than 5 steps, but subject recovers unaided. Moderate: Stands safely, but with absence of postural response; falls if not caught by examiner. Severe: Very unstable, tends to lose balance spontaneously or with just a gentle pull on the shoulders.
Change in MDS-UPDRS-III (section 3.13. Posture) score
0: Normal: No problems. Slight: Not quite erect, but posture could be normal for older person. Mild: Definite flexion, scoliosis or leaning to one side, but patient can correct posture to normal posture when asked to do so. Moderate: Stooped posture, scoliosis or leaning to one side that cannot be corrected volitionally to a normal posture by the patient. Severe: Flexion, scoliosis or leaning with extreme abnormality of posture.

Secondary Outcome Measures

Change in power spectrum density of Local Fields Potential (LFP) (micro-volts-squared per Hz)
Power spectrum density will show the strength of the variations (energy) as a function of frequency. In other words, it shows at which frequencies variations are strong and at which frequencies variations are weak.

Full Information

First Posted
February 28, 2023
Last Updated
August 2, 2023
Sponsor
Johns Hopkins University
search

1. Study Identification

Unique Protocol Identification Number
NCT05763732
Brief Title
Effects of RAS on Gait in PD Patients With DBS
Official Title
Effects of Rhythmic Auditory Stimulation (RAS) on Gait in Parkinson Disease (PD) Patients With DBS
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 1, 2023 (Actual)
Primary Completion Date
April 2024 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Participants will be asked to walk along with the metronome beats (RAS) during the participants' stimulation state (ON or OFF) for four minutes for each state. The researcher will collect the gait parameters (cadence, velocity, and stride length) of patients before, during, and after RAS in both DBS ON and OFF states. Using MDS-UPDRS, participants' gait patterns will be collected before and after RAS while both DBS is ON and OFF. Electrophysiological activity (local field potentials, LFPs) will be collected across all stages (pre, during, and post-RAS) of evaluation.
Detailed Description
Given the evidence that rhythmic auditory stimulation (RAS) can modulate beta oscillation and improve gait parameters, the purpose of this study is to examine behavioral and neurophysiological rhythmic entrainment mechanisms. Participants who complete the consent and enrollment process will remain for an additional up to 1 hour following the participants' routine clinic visit at the Jons Hopkins Outpatient Clinic. The protocol will consist of two parts (DBS ON and DBS OFF). The order of stimulation states will be randomly assigned to the participants. During DBS ON, participants will receive the participants' previously optimized stimulation after a 10-minute washout period. The researchers will measure participants' gait parameters (cadence, velocity, and stride length) with a 2-minute walk (a set distance of 10 meters during the 2-minute walk) and gait patterns using relevant items from the MDS-UPDRS-III rating scale during stimulation ON (Pre-RAS). The participants will then walk to the metronome beats for a total of four minutes (2 minutes for the same beat as baseline cadence and 2 minutes for 10% faster than baseline cadence) (RAS), and the gait parameters will be recorded. The order of the tempo will be randomized across the participants. Finally, after this 4-minute walk, the same assessment as for Pre-RAS will be conducted (Post-RAS). Electrophysiological activity (local field potentials, LFPs) will be collected across all stages (pre, during, and post-RAS) of evaluation. In DBS OFF, there will be a separate 10-minute washout period if it is taking place after DBS ON so that the participant's brain circuits can adjust to not being stimulated. Except for the DBS stimulation state, DBS OFF will follow the same protocol as DBS ON above.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease
Keywords
Parkinson disease, Deep brain stimulation, Rhythmic auditory stimulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Masking Description
The participant and outcomes assessor will be masked to the participants' stimulation state (OFF or ON). However, they cannot be masked whether they will receive rhythmic auditory stimulation (RAS) or not (pre-RAS or post-RAS).
Allocation
Randomized
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Pre RAS
Arm Type
No Intervention
Arm Description
After a 10-minute washout period, participants will receive the participants' optimized stimulation. The participants will undergo assessments to measure gait parameters and patterns during stimulation ON and OFF (Pre-RAS) using the 10-meter walk (during a 2-minute walk) and MDS-UPDRS-III rating scale. Electrophysiological activity (e.g., local field potentials, LFPs) will be collected before assessments.
Arm Title
During RAS
Arm Type
Experimental
Arm Description
The participants will walk to the metronome beats for four minutes (2 minutes for the same beats as baseline cadence and 2 minutes for 10% faster than baseline cadence) (RAS), and the participants' gait parameters will be recorded. Electrophysiological activity (e.g., local field potentials, LFPs) will be collected.
Arm Title
Post RAS
Arm Type
No Intervention
Arm Description
The same assessment as the Pre-RAS will be conducted (Post-RAS).
Intervention Type
Behavioral
Intervention Name(s)
Rhythmic Auditory Stimulation (RAS)
Intervention Description
Rhythmic auditory stimulus (RAS) is a Neurologic Music Therapy (NMT) technique that utilizes an auditory rhythmic cue to entrain gait to a specific rhythm. RAS, as an anticipatory time cue, can be used as both an immediate entrainment stimulus, providing rhythmic cues during movement, and as a facilitating stimulus for planning and executing a movement to achieve more functional gait patterns. Cadence, gait velocity, and stride length are the commonly used parameters to monitor changes in a patient's gait.
Primary Outcome Measure Information:
Title
Change in gait cadence (steps/minute)
Description
Gait cadence will be calculated with a 10-meter walk. Cadence (steps/min) = 60 / time (seconds) x # of steps
Time Frame
0 minute (Baseline 1, DBS ON), 5 minutes, 10 minutes, 20 minutes (Baseline 2, DBS OFF), 25 minutes, and 30 minutes
Title
Change in gait velocity (meter/minute)
Description
Gait velocity will be calculated with a 10-meter walk. Velocity(meter/min) = 60 / time (seconds) x 10 meter
Time Frame
0 minute (Baseline 1, DBS ON), 5 minutes, 10 minutes, 20 minutes (Baseline 2, DBS OFF), 25 minutes, and 30 minutes
Title
Change in gait stride length (meter)
Description
Gait stride length will be calculated with a 10-meter walk. Stride length (meter) = Velocity / Cadence x 2
Time Frame
0 minute (Baseline 1, DBS ON), 5 minutes, 10 minutes, 20 minutes (Baseline 2, DBS OFF), 25 minutes, and 30 minutes
Title
Changes in MDS-UPDRS-III (section 3.9. Arising From Chair ) score
Description
0: Normal: No problems. Able to arise quickly without hesitation. Slight: Arising is slower than normal; or may need more than one attempt; or may need to move forward in the chair to arise. No need to use the arms of the chair. Mild: Pushes self up from the arms of the chair without difficulty. Moderate: Needs to push off, but tends to fall back; or may have to try more than one time using the arms of the chair, but can get up without help. Severe: Unable to arise without help.
Time Frame
0 minute (Baseline 1, DBS ON), 10 minutes, 20 minutes (Baseline 2, DBS OFF), 30 minutes
Title
Change in MDS-UPDRS-III (section 3.10. Gait) score
Description
0: Normal: No problems. Slight: Independent walking with minor gait impairment. Mild: Independent walking but with substantial gait impairment. Moderate: Requires an assistance device for safe walking (walking stick, walker) but not a person. Severe: Cannot walk at all or only with another person's assistance.
Time Frame
0 minute (Baseline 1, DBS ON), 10 minutes, 20 minutes (Baseline 2, DBS OFF), 30 minutes
Title
Change in MDS-UPDRS-III (section 3.11. Freezing of gait) score
Description
0: Normal: No freezing. Slight: Freezes on starting, turning, or walking through doorway with a single halt during any of these events, but then continues smoothly without freezing during straight walking. Mild: Freezes on starting, turning, or walking through doorway with more than one halt during any of these activities, but continues smoothly without freezing during straight walking. Moderate: Freezes once during straight walking. Severe: Freezes multiple times during straight walking.
Time Frame
0 minute (Baseline 1, DBS ON), 10 minutes, 20 minutes (Baseline 2, DBS OFF), 30 minutes
Title
Change in MDS-UPDRS-III (section 3.12. Postural stability) score
Description
0: Normal: No problems. Recovers with one or two steps. Slight: 3-5 steps, but subject recovers unaided. Mild: More than 5 steps, but subject recovers unaided. Moderate: Stands safely, but with absence of postural response; falls if not caught by examiner. Severe: Very unstable, tends to lose balance spontaneously or with just a gentle pull on the shoulders.
Time Frame
0 minute (Baseline 1, DBS ON), 10 minutes, 20 minutes (Baseline 2, DBS OFF), 30 minutes
Title
Change in MDS-UPDRS-III (section 3.13. Posture) score
Description
0: Normal: No problems. Slight: Not quite erect, but posture could be normal for older person. Mild: Definite flexion, scoliosis or leaning to one side, but patient can correct posture to normal posture when asked to do so. Moderate: Stooped posture, scoliosis or leaning to one side that cannot be corrected volitionally to a normal posture by the patient. Severe: Flexion, scoliosis or leaning with extreme abnormality of posture.
Time Frame
0 minute (Baseline 1, DBS ON), 10 minutes, 20 minutes (Baseline 2, DBS OFF), 30 minutes
Secondary Outcome Measure Information:
Title
Change in power spectrum density of Local Fields Potential (LFP) (micro-volts-squared per Hz)
Description
Power spectrum density will show the strength of the variations (energy) as a function of frequency. In other words, it shows at which frequencies variations are strong and at which frequencies variations are weak.
Time Frame
0 minute (Baseline 1, DBS ON), 5 minutes, 10 minutes, 20 minutes (Baseline 2, DBS OFF), 25 minutes, and 30 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients diagnosed with Parkinson disease (PD) (and) PD patients who implanted Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) with PerceptTM PC Exclusion Criteria: Inability or unwillingness to follow directions for study procedures
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alexander Pantelyat, MD
Phone
4105023290
Email
apantel1@jhmi.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Kyurim Kang, Ph.D.
Email
kkang19@jhmi.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alexander Pantelyat, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins School of Medicine
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21205
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexander Pantelyat, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26558788
Citation
Fujioka T, Ross B, Trainor LJ. Beta-Band Oscillations Represent Auditory Beat and Its Metrical Hierarchy in Perception and Imagery. J Neurosci. 2015 Nov 11;35(45):15187-98. doi: 10.1523/JNEUROSCI.2397-15.2015.
Results Reference
background
PubMed Identifier
32849240
Citation
Naro A, Pignolo L, Sorbera C, Latella D, Billeri L, Manuli A, Portaro S, Bruschetta D, Calabro RS. A Case-Controlled Pilot Study on Rhythmic Auditory Stimulation-Assisted Gait Training and Conventional Physiotherapy in Patients With Parkinson's Disease Submitted to Deep Brain Stimulation. Front Neurol. 2020 Aug 4;11:794. doi: 10.3389/fneur.2020.00794. eCollection 2020.
Results Reference
background
PubMed Identifier
19673759
Citation
Fujioka T, Trainor LJ, Large EW, Ross B. Beta and gamma rhythms in human auditory cortex during musical beat processing. Ann N Y Acad Sci. 2009 Jul;1169:89-92. doi: 10.1111/j.1749-6632.2009.04779.x.
Results Reference
background
PubMed Identifier
33765395
Citation
Jimenez-Shahed J. Device profile of the percept PC deep brain stimulation system for the treatment of Parkinson's disease and related disorders. Expert Rev Med Devices. 2021 Apr;18(4):319-332. doi: 10.1080/17434440.2021.1909471. Epub 2021 Apr 5.
Results Reference
background
PubMed Identifier
33941932
Citation
Gilron R, Little S, Perrone R, Wilt R, de Hemptinne C, Yaroshinsky MS, Racine CA, Wang SS, Ostrem JL, Larson PS, Wang DD, Galifianakis NB, Bledsoe IO, San Luciano M, Dawes HE, Worrell GA, Kremen V, Borton DA, Denison T, Starr PA. Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson's disease. Nat Biotechnol. 2021 Sep;39(9):1078-1085. doi: 10.1038/s41587-021-00897-5. Epub 2021 May 3.
Results Reference
background
PubMed Identifier
30181135
Citation
Torrecillos F, Tinkhauser G, Fischer P, Green AL, Aziz TZ, Foltynie T, Limousin P, Zrinzo L, Ashkan K, Brown P, Tan H. Modulation of Beta Bursts in the Subthalamic Nucleus Predicts Motor Performance. J Neurosci. 2018 Oct 10;38(41):8905-8917. doi: 10.1523/JNEUROSCI.1314-18.2018. Epub 2018 Sep 4.
Results Reference
background

Learn more about this trial

Effects of RAS on Gait in PD Patients With DBS

We'll reach out to this number within 24 hrs